02359

181.5003.61%
QY

Qing Yang

Co-CEO & Executive Director

Dr. Qing Yang, also known as Steve, Ph.D. serves as Co-Chief Executive Officer at WuXi AppTec Co., Ltd. since May 21, 2020. Dr. Yang served as Chief Business Officer and Head of LTD at WuXi AppTec Co., Ltd. until May 2020 and served as Chief Strategy Officer since March 9, 2017 and served as its Executive Vice President until May 2020. Dr. Yang serves as an Executive Director of WuXi AppTec Co., Ltd. since May 15, 2020 and served as its Head of RSD and had been its Head of WuXi Testing since May 2020 until December 2020. Dr. Yang joined WuXi AppTec Co., Ltd. in April 2014. He has been the Chief Operating Officer at WuXi PharmaTech (Cayman) Inc. since April 15, 2014 and its Chief Business Officer and Chief Strategy Officer since March 7, 2017. He served as the Chief Operating Officer of WuXi AppTec Co., Ltd. until March 9, 2017. He served as an Executive Vice President at WuXi PharmaTech (Cayman) Inc. since April 15, 2014 until March 7, 2017. He is a pharmaceutical industry leader recognized for building R&D capabilities, delivering research and early development portfolios of drug candidates and establishing R&D partnerships in China and other Asian and emerging markets. Before joining WuXi, he served as Vice President and Head of Research & Development (R&D) for its Asia & Emerging Markets Business for AstraZeneca PLC since January 6, 2011. He and his team transformed the mission of AstraZeneca Innovation Center China, delivered AstraZeneca's first preclinical drug candidate discovered in China, strengthened translational science capabilities, established research outsourcing strategic partnerships and facilitated and managed a series of scientific collaborations in China, Russia, Israel, Taiwan and Korea. He served as a Director since December 14, 2020 until June 30, 2023 at WuXi XDC Cayman Inc. Previously, he served as Vice President and Head of Asia Research & Development at Pfizer based in Shanghai and as an Executive Director and Head of Pfizer's Global R&D strategic management group based in the United States. Before joining Pfizer, he held a number of leadership positions at IntraBiotics Pharmaceuticals, a U.S.-based biotech company. He also worked for Strategic Decisions Group, a strategy consulting firm for Fortune 100 companies. Dr. Yang co-founded the BayHelix Group, a non-profit Global Professional Organization of Chinese life science business leaders and served as the Chairman for two terms. He holds Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco.

Positions